Biomea Fusion Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019
Cash & Equivalents	177.24	112.25	146.09	61.7	0.24
Short-Term Investments	0	1.15	27.78	0	0
Cash & Cash Equivalents	177.24	113.4	173.87	61.7	0.24
Cash Growth	56.29%	-34.78%	181.82%	25713.81%	-
Other Current Assets	1.95	4.42	2.69	0.53	0.03
Total Current Assets	179.18	117.82	176.56	62.22	0.27
Property, Plant & Equipment	14.87	7.99	5.69	0.29	0
Long-Term Investments	0	0	1.88	0	0
Other Long-Term Assets	5.87	3.5	1.58	0.01	0
Total Long-Term Assets	20.75	11.49	9.14	0.3	0
Total Assets	199.93	129.31	185.71	62.53	0.27
Accounts Payable	6.85	6.83	1.33	0.73	0.27
Current Debt	2.47	0.62	0.57	0.26	0
Other Current Liabilities	13.54	11.66	2.74	0.63	0.02
Total Current Liabilities	22.86	19.1	4.64	1.62	0.29
Long-Term Debt	7.83	1.67	2.29	0	0
Total Long-Term Liabilities	7.83	1.67	2.29	0	0
Total Liabilities	30.69	20.77	6.92	1.62	0.29
Total Debt	10.3	2.29	2.85	0.26	0
Debt Growth	350.59%	-19.82%	1000.39%	-	-
Retained Earnings	-248.83	-131.57	-49.74	-8.18	-2.85
Comprehensive Income	0	-0	-0.01	0	0
Shareholders' Equity	169.24	108.54	178.78	5.17	-0.02
Net Cash / Debt	166.94	111.12	171.02	61.44	0.24
Net Cash / Debt Growth	50.24%	-35.03%	178.37%	25605.44%	-
Net Cash Per Share	4.89	3.80	7.17	5.83	0.04
Working Capital	156.32	98.72	171.92	60.6	-0.02
Book Value Per Share	4.96	3.71	7.49	0.49	-0.00

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).